PTH (Parathyroid Hormone)
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- PTH is the missing piece that explains why 'normal' calcium and vitamin D values can coexist with active bone loss. When vitamin D is chronically insufficient (25-OH vitamin D < 30 ng/mL), intestinal calcium absorption is reduced. PTH rises to compensate, driving bone resorption to maintain serum calcium. The calcium test looks normal — because PTH is maintaining it by dissolving bone. The vitamin D test shows deficiency — but patients are often simply told to take more vitamin D without understanding that their PTH was elevated and bone loss was already occurring. Testing all three together (calcium + PTH + vitamin D) reveals the complete picture.
- The longevity-optimal PTH range is the lower half of the standard range — chronic PTH elevation within 'normal' accelerates bone loss. PTH's primary mechanism for raising calcium is bone resorption — breaking down cortical and trabecular bone to release calcium. Even PTH values in the upper portion of the normal range (50–65 pg/mL), when sustained over years, produce measurable net bone loss compared to values in the lower portion (20–35 pg/mL). Vitamin D optimization is the primary lever for reducing PTH to the lower normal range by supporting calcium absorption and reducing the compensatory PTH stimulus.
- PTH above 65 pg/mL in a person with normal calcium should prompt evaluation for vitamin D deficiency, kidney function impairment, or magnesium deficiency. Secondary hyperparathyroidism from vitamin D deficiency is far more common than primary hyperparathyroidism. But other causes include declining kidney function (the kidney is required to activate vitamin D and excrete phosphorus, and as GFR falls, PTH rises), magnesium deficiency (which impairs both PTH secretion and vitamin D activation), severe calcium deficiency, and malabsorption conditions. The workup should include 25-OH vitamin D, serum calcium, magnesium, phosphorus, and kidney function tests.
- PTH interacts with cardiovascular health through effects beyond bone. Chronic PTH elevation has direct cardiovascular effects independent of its bone actions. PTH receptors are expressed on cardiac myocytes and vascular smooth muscle cells; chronically elevated PTH promotes left ventricular hypertrophy, endothelial dysfunction, and arterial calcification. Multiple observational studies have found that elevated PTH (both from primary hyperparathyroidism and from vitamin D deficiency-driven secondary hyperparathyroidism) is independently associated with higher rates of cardiovascular disease, hypertension, and all-cause mortality. This cardiovascular dimension adds importance to PTH normalization beyond bone protection alone.
- Magnesium deficiency is a frequently overlooked cause of elevated PTH — and of impaired response to vitamin D supplementation. Magnesium is required for both PTH secretion (paradoxically — both severe deficiency and excess magnesium impair PTH) and for the enzymatic conversion of 25-OH vitamin D to active 1,25-dihydroxyvitamin D. People with persistent PTH elevation despite adequate vitamin D supplementation should have serum or RBC magnesium checked — magnesium deficiency may be blocking normal vitamin D activation and preventing PTH normalization.
The Silent Bone Thief: Secondary Hyperparathyroidism from Vitamin D Deficiency
Primary hyperparathyroidism — the autonomous parathyroid adenoma that drives calcium above normal and requires surgical treatment — is the dramatic version of PTH excess. It produces obvious laboratory abnormalities (high calcium, high PTH) and, though underdiagnosed, is eventually caught when abnormal calcium is noticed on a routine metabolic panel.
The more common and more insidious problem is secondary hyperparathyroidism from vitamin D deficiency. Here, the serum calcium remains normal — because elevated PTH is successfully defending it by resorbing bone. The calcium test looks reassuring. The vitamin D test shows deficiency, but this is often communicated without the PTH context. The PTH itself is rarely tested unless a physician specifically orders it.
The result is millions of people with deficient vitamin D and elevated PTH who have 'normal' calcium and are told to supplement vitamin D, without understanding that bone loss is already occurring through chronically elevated PTH-driven osteoclast activity. Testing all three together — calcium, vitamin D, and PTH — transforms the interpretation entirely and allows confirmation of whether vitamin D supplementation is adequately reducing the PTH stimulus to bone resorption.
The Calcium-PTH-Vitamin D Triangle
These three markers form an interdependent regulatory triangle. You cannot fully interpret any one of them without the other two. The diagnostic patterns that emerge from their combination are:
High calcium + High PTH: Primary hyperparathyroidism. The parathyroids are secreting PTH regardless of calcium level. Requires parathyroid evaluation, typically surgical adenoma removal.
Normal calcium + High PTH + Low vitamin D: Secondary hyperparathyroidism from vitamin D deficiency. The most common pattern. Bone is being dissolved to maintain normal calcium. First-line treatment: vitamin D repletion, confirm PTH normalization on follow-up.
High calcium + Low PTH: Non-parathyroid cause of hypercalcemia. PTH is appropriately suppressed, but something else is raising calcium — malignancy, sarcoidosis, vitamin D toxicity. Requires workup for these conditions.
Low calcium + Low PTH: Hypoparathyroidism. The parathyroids are not responding to low calcium with adequate PTH. Can be post-surgical (parathyroid removed during thyroid surgery), autoimmune, or genetic. 1
| PTH Level | Calcium | Interpretation |
|---|---|---|
| 20–45 pg/mL | 9.0–9.8 mg/dL | Longevity optimal — balanced mineral metabolism |
| 45–65 pg/mL | Normal | Check vitamin D; optimize if < 40 ng/mL |
| > 65 pg/mL | Normal to low-normal | Secondary hyperparathyroidism — evaluate vitamin D, Mg, kidney function |
| > 65 pg/mL | > 10.2 mg/dL | Primary hyperparathyroidism — parathyroid evaluation indicated |
| < 15 pg/mL | Low | Hypoparathyroidism — clinical evaluation |
| Range Type | Value (pg/mL) | Notes |
|---|---|---|
| Standard Clinical Range | Adults: 15–65 pg/mL (intact PTH; ranges vary slightly by laboratory) | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | 20–45 pg/mL |
Associated with reduced all-cause mortality and extended healthspan.
PTH must always be interpreted in the context of simultaneous serum calcium, vitamin D, phosphorus, and kidney function. Elevated PTH with high calcium confirms primary hyperparathyroidism. Elevated PTH with low-normal calcium and low vitamin D confirms vitamin D deficiency-driven secondary hyperparathyroidism — the most common clinical scenario. Elevated PTH with low calcium and normal or high vitamin D in the setting of declining kidney function indicates tertiary or renal hyperparathyroidism. PTH in the upper portion of the normal range (50–65 pg/mL) combined with vitamin D in the low-normal range (25–35 ng/mL) and calcium trending toward the upper-normal range represents a subtle but meaningful signal of suboptimal mineral metabolism that precedes overt disease.
|
Already have your results? See what your PTH (Parathyroid Hormone) and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
What is the ideal time of day to test PTH?
PTH shows meaningful diurnal variation: levels are higher in the late afternoon and at night, and lower in the morning — influenced by the nocturnal bone resorption cycle and cortisol's interaction with the calcium-PTH axis. For longevity monitoring and comparison across measurements, morning fasting draws are preferred. Drawing PTH in the morning with fasting produces more stable and reproducible results than afternoon draws. If you're getting calcium, vitamin D, and PTH together (which is the recommended approach for a complete mineral metabolism assessment), a morning fasting draw handles all three appropriately.
How does vitamin D supplementation affect PTH?
When vitamin D deficiency is the driver of elevated PTH, supplementing vitamin D typically reduces PTH over weeks to months as vitamin D levels rise and intestinal calcium absorption improves. The usual trajectory: vitamin D supplementation → rising 25-OH vitamin D → improved calcium absorption → less stimulus for compensatory PTH secretion → gradual PTH decline toward the lower portion of normal. The degree of PTH reduction depends on how deficient the baseline vitamin D was, whether calcium intake is adequate to support the improved absorption, and whether magnesium status is adequate for vitamin D activation. Not everyone with elevated PTH responds dramatically to vitamin D — some people have PTH elevation from non-vitamin D causes, and some have impaired vitamin D activation from magnesium deficiency or kidney function decline. Measuring PTH again 3–6 months after establishing adequate vitamin D levels (above 40–50 ng/mL) confirms whether vitamin D was the driver.
What is secondary vs. tertiary hyperparathyroidism?
Primary hyperparathyroidism is autonomous PTH secretion from a parathyroid adenoma (the parathyroid glands don't respond normally to high calcium). Secondary hyperparathyroidism is appropriate PTH elevation in response to a stimulus — most commonly vitamin D deficiency or chronic kidney disease (CKD), where reduced vitamin D activation and phosphorus retention drive persistent hypocalcemia or relative calcium deficiency that stimulates PTH. In secondary hyperparathyroidism, calcium is low-normal or normal, while PTH is elevated. Tertiary hyperparathyroidism occurs when long-standing secondary hyperparathyroidism (usually in advanced CKD) leads to autonomous PTH secretion even after the original stimulus is removed — a transition from compensatory to autonomous behavior. This can occur after kidney transplantation, where the transplant restores kidney function but the parathyroid glands continue secreting excess PTH autonomously.
What is the significance of PTH in the context of kidney disease?
PTH and kidney function are deeply linked through multiple pathways. The kidneys activate vitamin D (converting 25-OH vitamin D to active 1,25-dihydroxyvitamin D) and excrete phosphorus. As kidney function declines (falling eGFR), both vitamin D activation and phosphorus excretion are impaired. Reduced active vitamin D lowers intestinal calcium absorption. Rising phosphorus directly suppresses PTH inappropriately. The combined effect drives a progressive rise in PTH — secondary hyperparathyroidism of CKD — that accelerates bone loss and contributes to the dramatically elevated cardiovascular mortality of CKD. PTH above 65 pg/mL in a person with eGFR below 60 mL/min/1.73m² should prompt nephrology evaluation for mineral and bone disorder management — a major focus of CKD care. PTH monitoring is a standard component of CKD management guidelines.